Effectiveness of Tysabri in SPMS study

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Effectiveness of Tysabri in SPMS study

Postby MSUK » Thu Jan 26, 2012 7:54 am

ASCEND study to evaluate the effectiveness of Tysabri in secondary progressive MS


Biogen Idec today announced a global Phase 3b study, ASCEND, that is being conducted to evaluate the effectiveness of Tysabri as a treatment for secondary-progressive multiple sclerosis (SPMS). According to the National Multiple Sclerosis Society, approximately half of all people initially diagnosed with relapsing-remitting multiple sclerosis (RRMS) - the most common form of multiple sclerosis (MS) - will transition to SPMS within 19 years.

Patients with RRMS typically experience unpredictable relapses; the time between relapses is characterised by full or partial recovery and a lack of disease progression. SPMS is characterized by a steady progression of nerve damage, symptoms and disability, but the exact reasons for the progression are unknown. The potential for greater disease burden in SPMS typically includes decreased mobility, impaired activities of daily living, loss of independence and reduced quality of life.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Re: Effectiveness of Tysabri in SPMS study

Postby HarryZ » Fri Jan 27, 2012 7:30 am

The ASCEND study is part of the ongoing commitment of both Biogen Idec and Elan to find ways to improve the well-being of patients with multiple sclerosis.

After reading the two recent threads on ThisIsMS (ex pharma sales rep and the industry actions of drug companies) I have a very difficult time putting one ounce of credibility in that statement!!
User avatar
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada

Return to Tysabri (Antegren or Natalizumab)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service